Loading…
HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study
Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendat...
Saved in:
Published in: | International journal of STD & AIDS 2007-05, Vol.18 (5), p.351-353 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c402t-3045e7a10ff2b57417403a829f74849d12355a1871bcd90a2be924eda78c93ee3 |
---|---|
cites | |
container_end_page | 353 |
container_issue | 5 |
container_start_page | 351 |
container_title | International journal of STD & AIDS |
container_volume | 18 |
creator | FERNANDEZ-IBIETA, Maria RAMOS-AMADOR, José T AUNON-MARTIN, Ismael |
description | Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal. |
doi_str_mv | 10.1258/095646207780749763 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70555690</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_095646207780749763</sage_id><sourcerecordid>70555690</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-3045e7a10ff2b57417403a829f74849d12355a1871bcd90a2be924eda78c93ee3</originalsourceid><addsrcrecordid>eNqF0U1P3DAQBmCralUW2j_AAfnS3gJjx47t3hCigITEpR_HaNaZFKOss7WTlfbf49WuxAEJTj74mdeeGcZOBZwLqe0FON2oRoIxFoxypqk_sIUw2lYCtPzIFjtQFaGO2HHOTwDQ1MZ9ZkcFSSVBLFi4vftThdiTn6jj_jEMXaLIN-h9iDiFMXI_bijhP-IYO56xp2nLQ-TI_1KeKEV-PadxTbiTj2OafpSrRFMa87qkhg3xPM3d9gv71OOQ6evhPGG_f17_urqt7h9u7q4u7yuvQE5VDUqTQQF9L5faKGEU1Gil642yynVC1lqjsEYsfecA5ZKcVNShsd7VRPUJ-77PXafx_1y-2K5C9jQMGGmcc2tAa904eBcKZ4QStS1Q7qEvPeVEfbtOYYVp2wpod5toX2-iFJ0d0uflirqXksPoC_h2AJg9Dn3C6EN-cdY0IBtV3MXe5bKD9mmcUyzje-vpZ0ILnbY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19714138</pqid></control><display><type>article</type><title>HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study</title><source>Sage Journals Online</source><creator>FERNANDEZ-IBIETA, Maria ; RAMOS-AMADOR, José T ; AUNON-MARTIN, Ismael</creator><creatorcontrib>FERNANDEZ-IBIETA, Maria ; RAMOS-AMADOR, José T ; AUNON-MARTIN, Ismael</creatorcontrib><description>Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.</description><identifier>ISSN: 0956-4624</identifier><identifier>EISSN: 1758-1052</identifier><identifier>DOI: 10.1258/095646207780749763</identifier><identifier>PMID: 17524201</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adolescent ; Adult ; AIDS/HIV ; Biological and medical sciences ; Child ; Child, Preschool ; Cohort Studies ; Epidemiology. Vaccinations ; General aspects ; Hepatitis B virus ; HIV Infections - complications ; HIV Infections - immunology ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Immunization Schedule ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infant ; Infectious diseases ; Mass Vaccination - utilization ; Medical sciences ; Neisseria meningitidis ; Patient Compliance ; Retrospective Studies ; Spain ; Streptococcus pneumoniae ; Urban Population ; Vaccines - administration & dosage ; Varicella-zoster virus ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>International journal of STD & AIDS, 2007-05, Vol.18 (5), p.351-353</ispartof><rights>2007 Royal Society of Medicine Press</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-3045e7a10ff2b57417403a829f74849d12355a1871bcd90a2be924eda78c93ee3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18760264$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17524201$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FERNANDEZ-IBIETA, Maria</creatorcontrib><creatorcontrib>RAMOS-AMADOR, José T</creatorcontrib><creatorcontrib>AUNON-MARTIN, Ismael</creatorcontrib><title>HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study</title><title>International journal of STD & AIDS</title><addtitle>Int J STD AIDS</addtitle><description>Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.</description><subject>Adolescent</subject><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Hepatitis B virus</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - immunology</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunization Schedule</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Mass Vaccination - utilization</subject><subject>Medical sciences</subject><subject>Neisseria meningitidis</subject><subject>Patient Compliance</subject><subject>Retrospective Studies</subject><subject>Spain</subject><subject>Streptococcus pneumoniae</subject><subject>Urban Population</subject><subject>Vaccines - administration & dosage</subject><subject>Varicella-zoster virus</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0956-4624</issn><issn>1758-1052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqF0U1P3DAQBmCralUW2j_AAfnS3gJjx47t3hCigITEpR_HaNaZFKOss7WTlfbf49WuxAEJTj74mdeeGcZOBZwLqe0FON2oRoIxFoxypqk_sIUw2lYCtPzIFjtQFaGO2HHOTwDQ1MZ9ZkcFSSVBLFi4vftThdiTn6jj_jEMXaLIN-h9iDiFMXI_bijhP-IYO56xp2nLQ-TI_1KeKEV-PadxTbiTj2OafpSrRFMa87qkhg3xPM3d9gv71OOQ6evhPGG_f17_urqt7h9u7q4u7yuvQE5VDUqTQQF9L5faKGEU1Gil642yynVC1lqjsEYsfecA5ZKcVNShsd7VRPUJ-77PXafx_1y-2K5C9jQMGGmcc2tAa904eBcKZ4QStS1Q7qEvPeVEfbtOYYVp2wpod5toX2-iFJ0d0uflirqXksPoC_h2AJg9Dn3C6EN-cdY0IBtV3MXe5bKD9mmcUyzje-vpZ0ILnbY</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>FERNANDEZ-IBIETA, Maria</creator><creator>RAMOS-AMADOR, José T</creator><creator>AUNON-MARTIN, Ismael</creator><general>SAGE Publications</general><general>Royal Society of Medicine Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T5</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study</title><author>FERNANDEZ-IBIETA, Maria ; RAMOS-AMADOR, José T ; AUNON-MARTIN, Ismael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-3045e7a10ff2b57417403a829f74849d12355a1871bcd90a2be924eda78c93ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Hepatitis B virus</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - immunology</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunization Schedule</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Mass Vaccination - utilization</topic><topic>Medical sciences</topic><topic>Neisseria meningitidis</topic><topic>Patient Compliance</topic><topic>Retrospective Studies</topic><topic>Spain</topic><topic>Streptococcus pneumoniae</topic><topic>Urban Population</topic><topic>Vaccines - administration & dosage</topic><topic>Varicella-zoster virus</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FERNANDEZ-IBIETA, Maria</creatorcontrib><creatorcontrib>RAMOS-AMADOR, José T</creatorcontrib><creatorcontrib>AUNON-MARTIN, Ismael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of STD & AIDS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FERNANDEZ-IBIETA, Maria</au><au>RAMOS-AMADOR, José T</au><au>AUNON-MARTIN, Ismael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study</atitle><jtitle>International journal of STD & AIDS</jtitle><addtitle>Int J STD AIDS</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>18</volume><issue>5</issue><spage>351</spage><epage>353</epage><pages>351-353</pages><issn>0956-4624</issn><eissn>1758-1052</eissn><abstract>Since the implementation of highly active antiretroviral therapy in HIV-infected children, response to scheduled vaccines may determinate future morbidity and mortality. The aims of this study have been to describe the current vaccine coverage, vaccine safety and concordance with vaccine recommendations of the 68 HIV-infected children and adolescents followed up in our Unit. Forty-four percent of the children received at least one dose of the oral polio vaccine (OPV). Only 9.1% needed and received a second set of hepatitis B virus immunization because of low vaccine response. Only 14.7% were vaccinated against varicella. Coverages of 82.3% and 100% have been reached with the 23-valent and the 7-valent pneumococcal vaccines, respectively. Meningococcal conjugated vaccine uptake was moderate (80.8%). Influenza annual vaccination coverage was poor: only 22.7% had well-documented yearly vaccines. In our experience, vaccine coverage is lower in those vaccines administered in primary care centres compared with the immunizations given at the hospital. OPV administration did not cause any adverse effect in the children or in their families. Vaccine coverage in HIV-infected children was suboptimal.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>17524201</pmid><doi>10.1258/095646207780749763</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0956-4624 |
ispartof | International journal of STD & AIDS, 2007-05, Vol.18 (5), p.351-353 |
issn | 0956-4624 1758-1052 |
language | eng |
recordid | cdi_proquest_miscellaneous_70555690 |
source | Sage Journals Online |
subjects | Adolescent Adult AIDS/HIV Biological and medical sciences Child Child, Preschool Cohort Studies Epidemiology. Vaccinations General aspects Hepatitis B virus HIV Infections - complications HIV Infections - immunology Human immunodeficiency virus Human viral diseases Humans Immunization Schedule Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infant Infectious diseases Mass Vaccination - utilization Medical sciences Neisseria meningitidis Patient Compliance Retrospective Studies Spain Streptococcus pneumoniae Urban Population Vaccines - administration & dosage Varicella-zoster virus Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
title | HIV-infected children vaccination coverage and safety in a Western European cohort: a retrospective study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A04%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV-infected%20children%20vaccination%20coverage%20and%20safety%20in%20a%20Western%20European%20cohort:%20a%20retrospective%20study&rft.jtitle=International%20journal%20of%20STD%20&%20AIDS&rft.au=FERNANDEZ-IBIETA,%20Maria&rft.date=2007-05-01&rft.volume=18&rft.issue=5&rft.spage=351&rft.epage=353&rft.pages=351-353&rft.issn=0956-4624&rft.eissn=1758-1052&rft_id=info:doi/10.1258/095646207780749763&rft_dat=%3Cproquest_cross%3E70555690%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-3045e7a10ff2b57417403a829f74849d12355a1871bcd90a2be924eda78c93ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19714138&rft_id=info:pmid/17524201&rft_sage_id=10.1258_095646207780749763&rfr_iscdi=true |